GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has closed its oversubscribed seed round at $1.77 million, with key investors TYDO and TELUS Ventures. Following early commercial success in Canada, this…
The SHRM (Society for Human Resource Management) on precision health & genetic testing for employers A recent SHRM article referenced the Precision Prescribing Software Review Infographic emphasizing that ‘Genetic testing can help with precision prescribing of medications, which takes into account…
Great attendance with many opportunities to connect with clients and partners. Thank you for visiting our booth to learn more about how precision prescribing software is transforming healthcare delivery making patient-centered care front and center. Traversing innovative technologies to enable the translation…
TreatGx is an evidence-based medication decision support system that provides personalized prescribing options for the management of common conditions. TreatGx logic trees include: 1. status of the condition being treated 2. previous non-pharmacological and pharmacological treatment(s) 3. current non-pharmacological and pharmacological…
We are thrilled to be selected to present our leading precision prescribing solution at MedCity Engage in San Diego on November 7th, 2018. During the contest at MedCity ENGAGE, promising startups offering innovative approaches and tackling the biggest problems in patient…
Bousman et al propose a minimum gene and allele set for pharmacogenetic testing in psychiatry that includes 16 variant alleles within five genes (CYP2C9, CYP2C19, CYP2D6, HLA-A,HLA-B). Genotype-guided prescribing with pharmacogenetics helps clinicians choose the right medication or dose for each…
We are thrilled to be selected to present our leading precision prescribing solution at the Healthcare Revolution conference in Orlando, Florida on October 28th, 2018. Global Healthcare Ventures joined forces with Global Healthcare Resources to showcase companies with high-growth market potential….
We are excited to announce the release of the new drug-drug interaction checker built right into the TreatGx software! The checker is powered by DrugBank, a comprehensive drug database containing more than 280,000 drug-drug interactions. The upgrade includes an easier-to-use interface…
GenXys, a precision prescribing software company tackling a $130 billion global problem, has announced plans to expand into new regions to improve patient safety, medication effectiveness and healthcare costs around the globe Vancouver, August 30, 2018. In response to increased demand…
The new ADHD algorithm in the TreatGx medication decision support software helps clinicians to more accurately dose ADHD medications. Attention deficit hyperactivity disorder (ADHD) is a mental disorder characterized by an ongoing pattern of behavioral symptoms that include inattentiveness, hyperactivity, and…
